Suchergebnisse - "Gupta, Neeraj"

PubPharm (650)

71

Future Opportunities in Drug Development : American Society for Clinical Pharmacology and Therapeutics Pharmacometrics and Pharmacokinetics Community Vision

enthalten in: Clinical Pharmacology & Therapeutics | 2023

von Burton, J. | Abuasal, B. | Bachhav, S. | +10

72

Population Pharmacokinetics of Mivavotinib (TAK‐659), a Dual Spleen Tyrosine Kinase and FMS‐Like Tyrosine Kinase 3 Inhibitor, in Patients With Advanced Solid Tumors or Hematologic Malignancies

enthalten in: The Journal of Clinical Pharmacology | 2023

von Li, C. | Watson, K. | Wang, S. | +2

73

A Phase 1 Drug‐Drug Interaction Study Between Brigatinib and the CYP3A Substrate Midazolam in Patients With ALK‐ Positive or ROS1‐Positive Solid Tumors

enthalten in: The Journal of Clinical Pharmacology | 2023

von Hanley, M. | D'Arcangelo, M. | Felip, E. | +5

74

Fabrication of pH‐sensitive double cross‐linked sodium alginate/chitosan hydrogels for controlled release of amoxicillin

enthalten in: Polymer Engineering & Science | 2023

von Feyisa, Z. | Gupta, N. | Edossa, G. | +3

75

Fabrication and Characterization of Cu Nanoparticles Dispersed on ZnAl-Layered Double Hydroxide Nanocatalysts for the Oxidation of Cyclohexane

enthalten in: ACS omega | 2022

von Kirar, J. | Gupta, N. | Chandra, K. | +4

76

Boron-containing proteasome inhibitors for use after primary cancer therapy

enthalten in: Europäisches Patentamt | 2022

von HUI AI-MIN | LABOTKA RICHARD | GUPTA NEERAJ | +2

77

Chronic hyperglycemia drives alterations in macrophage effector function in pulmonary tuberculosis

enthalten in: European journal of immunology | 2022

von Panda, S. | Seelan, D. | Faisal, S. | +8

78

Chronic hyperglycemia drives alterations in macrophage effector function in pulmonary tuberculosis

enthalten in: bioRxiv.org | 2022

von Panda, S. | Seelan, D. | Faisal, S. | +7

79

Comparative evaluation of colistin susceptibility testing by Disk Diffusion and Broth Microdilution methods : An experience from a tertiary care hospital

enthalten in: Infectious disorders drug targets | 2022

von Kaur, N. | Tak, V. | Nag, V. | +5

80

Phase 1 study to evaluate the effects of rifampin on pharmacokinetics of pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2022

von Zhou, X. | Vaishampayan, U. | Mahalingam, D. | +7